Skip to content

Effect of Dexmedetomidine on Graft Function After Kidney Transplantation: a Randomized, Double-Blind, Controlled Trial

Effect of Dexmedetomidine on Graft Function After Kidney Transplantation

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025493
Enrollment
Unknown
Registered
2019-08-28
Start date
2019-09-01
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end-stage renal disease

Interventions

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
21 Years to 67 Years

Inclusion criteria

Inclusion criteria: Adult patients aged >= 18 years with end-stage kidney disease who fulfill the criteria as a renal transplant candidate and are scheduled for deceased kidney allograft transplant under general anesthesia.

Exclusion criteria

Exclusion criteria: Sick sinus syndrome, atrioventricular block, known left ventricular ejection fraction < 30%, kidney combined with other organ transplants.

Design outcomes

Primary

MeasureTime frame
incidence of DGF;

Secondary

MeasureTime frame
repeated dialysis;acute rejection;Serum creatinine;Serum cystatin C;eGFR;Allograft survival;Patient survival;

Countries

China

Contacts

Public ContactFu-Hai Ji

The First Affiliated Hospital of Soochow University

jifuhai@hotmail.com+86 13656207331

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026